3'-Beta-C-Ethynyl-4-deoxyuridine

3'-Beta-C-Ethynyl-4-deoxyuridine is a purine nucleoside analog known for its broad antitumor activity targeting indolent lymphoid malignancies. Its anticancer mechanisms primarily involve the inhibition of DNA synthesis and induction of apoptosis, among other processes [1].